Home > Financial Ratios > THYROCARE TECHNOLOGIES

THYROCARE TECHNOLOGIES
Core EBITDA Growth

    Back to All Ratios
THYROCARE TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for THYROCARE TECHNOLOGIES
Please provide your vote to see the results

THYROCARE TECHNOLOGIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 13.12-50.5844.251.919.78

What is the latest Core EBITDA Growth ratio of THYROCARE TECHNOLOGIES ?

The latest Core EBITDA Growth ratio of THYROCARE TECHNOLOGIES is 13.12 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202413.12
Mar2023-50.58
Mar202244.25
Mar20211.91
Mar20209.78

How is Core EBITDA Growth of THYROCARE TECHNOLOGIES Trending?

Years Core EBITDA Growth % Change
Mar2024 13.12
Positive
Mar2023 -50.58
Negative
Mar2022 44.25
2,216.75
Mar2021 1.91
-80.47
Mar2020 9.78 -

Other Financial Ratios of THYROCARE TECHNOLOGIES


Compare Core EBITDA Growth ratio of peers of THYROCARE TECHNOLOGIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
THYROCARE TECHNOLOGIES ₹3,826.1 Cr -7% -15.3% 22.4% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹97,685.7 Cr -6.3% -2.4% 13.8% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹90,104.8 Cr -7.4% -8.2% -5.6% Stock Analytics
FORTIS HEALTHCARE ₹45,520.2 Cr -3.9% -6.5% 43.9% Stock Analytics
GLOBAL HEALTH ₹29,803.8 Cr -1.6% 8.8% -14.9% Stock Analytics
NARAYANA HRUDAYALAYA ₹27,167.7 Cr -4.5% 2.1% -6.2% Stock Analytics


THYROCARE TECHNOLOGIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
THYROCARE TECHNOLOGIES

-7%

-15.3%

22.4%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses